Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Zhengzhou University
Headquarters: Zhengzhou City, China
Website: http://english.zzu.edu.cn/
Year Founded: 1956
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Feb 26, 2025
Distillery Therapeutics
Small molecule inhibitor of KAT8 for esophageal cancer
BioCentury | Mar 5, 2024
Discovery & Translation
Distillery spotlight: new Alzheimer’s mechanisms from academia
BioCentury’s survey of the 2023 translational literature highlights a cluster of neuron-targeting mechanisms for Alzheimer’s disease
BioCentury | Aug 27, 2021
Distillery Therapeutics
Inhibiting HOXC10 or its circular RNA stabilizer for colorectal cancer
BioCentury | Feb 1, 2019
Product R&D
BlueRock’s PD purity play
Why BlueRock’s iPS cells could fare better in Parkinson’s than fetal transplants
BioCentury | Oct 13, 2016
Distillery Therapeutics
Therapeutics: SRY-box 4 (SOX4); long non-coding RNA SRY box 4 (LNCSOX4)
BioCentury | Oct 8, 2015
Distillery Techniques
Techniques: Co-crystal structure of fat mass and obesity associated (FTO) bound to an inhibitor
Items per page:
1 - 8 of 8